Latest news
Medicus Pharma CMO to lead Antev's Teverelix clinical programme - Proactive financial newsProactive financial news · Mon, 03 Aug 2026 14:02:54 GMTMedicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 31 Jul 2026 13:24:00 GMTMedicus Pharma Secures IND Authorization for Teverelix® Study in UAE - Intellectia AIIntellectia AI · Fri, 31 Jul 2026 11:54:47 GMTMedicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 11:40:00 GMTAbout 84 Women, Four Groups: Teverelix Endometriosis Trial - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTEXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi - SahmSahm · Fri, 31 Jul 2026 07:00:00 GMT